Neurolief Inc

🧠 Today is #BrainDonorAwarenessDay. Brain donors play a vital role in advancing neuroscience research. 🎙️Tune in to our 2022 podcast, "Brain Donation? There Are More Benefits Than You Think," with the Brain Donor Project to learn about the process: migrainedisorders.org/podcast/s4ep7-…

As Neurolief continues to explore Relivion for other neurological disorders, we received promising results for our MOOD Trial Interim Analysis for Depression. prnewswire.com/news-releases/…

A new FDA cleared device called Relivion is using the body's natural electricity as medicine to stimulate the two major nerve pathways involved in the #migraine process. We will break down everything you want to know about the device. Read now: migrainedisorders.org/relivion-migra…

New Data at AHS Annual Meeting Demonstrate Substantial Results for Patients Using Neurolief's Digital Therapeutics Technology to Treat #Migraine prnewswire.com/news-releases/…

The team is at #AHS in Austin, TX to share the latest news on RelivionMG - stop by the suite on the 4th Floor

The Relivion MG is a new category of #neurostimulation medical technology that targets the major nerve pathways in the brain associated with #migraine. Learn more about how it works at relivion.com/why-relivion/h…

Migraine Treatment Has Come a Long Way. This ‘woman’s disease’ doesn’t get a lot of research funding, but the medical establishment has made strides in developing new drugs and devices to combat migraine, by @lindy2350 nytimes.com/2022/07/14/wel… via @nytimeswell

🤔 What happens to your brain during a migraine? 🧠How does neuromodulation work? 💡What role does electricity play in all of this? We look to answer common questions we've received in this new blog post. Read on: relivion.com/power-of-elect…

Neurolief celebrates #ShadesForMigraine – a global awareness campaign to show support for the 1 billion people living with migraine disease worldwide. So put on a pair and join us in spreading the word! Learn more @ ow.ly/Vukb50JCINP #showyoucare #wearapair

#ShadesForMigraine - Today we join with advocates around the globe to educate and empower patients, spark conversations about migraine treatment options, and destigmatize the disease. Put on a pair and join us in spreading the word! #showyoucare #wearapair

🧠 New data released at the 64th Annual Scientific Meeting hosted by the American Headache Society (June 9-12th, 2022, Denver, CO). 🧠 einpresswire.com/article/576600… #innovation #medtechinnovator #medtech #medicaldevices

ICYM #AHS: Long-term Efficacy and Safety of External Combined Occipital and Trigeminal Nerve Stimulation in Migraine Prevention

@CMAware Stories like these are why advocacy is so crucial. Great post!

#CMAware #FacesOfChronicMigraine #AdvocateForAccess #MHAM #MHAM2022 #Migraine #ChronicMigraine

1 in 6 people in the UK live with a neuro condition but there simply isn’t the workforce or services in place to provide the support they need. This must change. Sign the petition now: tinyurl.com/BackThe1in6 #migraine #BackThe1in6

Exciting news on our SP301 study! The study is the first to prove that eCOT-NS can effectively treat migraine pain, with 76% of patients achieving headache relief within 2 hours compared to 31.6% of patients in the sham group. #neuromodulation Read on: ow.ly/VVvh50JuKB2

Today at #AHS2022 - New Poster: Spectrum of Response to Relivion MG in High-Frequency Episodic and Chronic #Migraine Patients Visit Poster P-197 in the Exhibit / Poster Hall Oral Presentation: 6/10 @ 1:55-2:00 pm MDT in Aurora Hall 3

Neurolief will be sharing new data this weekend at the AHS 64th Annual Scientific Meeting on #Relivion MG and preventive #migraine treatments. We'll have 2 posters at the event - be on the lookout! We hope to see you there!

Study shows 76% of patients treated with digital therapeutics #neuromodulation system achieved headache pain relief at 2 hours s.einnews.com/8e7A9jn-0N

External Concurrent Occipital and Trigeminal Neurostimulation Relieves #migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial Read the full article here: bit.ly/3NTgUN4

June is National Migraine & Headache Awareness Month (#MHAM). By raising awareness, we continue to push against the structural stigma that impacts people living with #migraine every day.